PF-04937319

DB15009InvestigationalSmall molecule

PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects).

Mechanism: Pharmacologically active on Hexokinase-4
Curator reviewed
Formula / weight: C₂₂H₂₀N₆O₄ · 432.432 g/mol (avg)
Code names: PF-04937319

Resolves to

Compound

UNII7E99B9ZM19CAS1245603-92-2ChEMBLCHEMBL2165615

Structure

InChIKeyMASKQITXHVYVFL-UHFFFAOYSA-NSMILESCN(C)C(=O)C1=NC=C(OC2=CC(=CC3=C2C=C(C)O3)C(=O)NC2=NC=C(C)N=C2)C=N1

Targets

P35557GCK

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-04937319, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account